#47 Public Company 🇺🇸 United States

Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company that operates a dual-structured corporate framework combining drug development with a DAT. Read more

BTC Holdings

1,000

As of Mar 31, 2025
BTC Value
$63.9M
Holdings BTC vs USD value
₿1,000
$63.9M USD value · as of Jun 21, 2026
BTC Holdings (left)
USD Value (right)
BitcoinTreasuries logo

Historical Holdings

About Apimeds Pharmaceuticals US, Inc.

Apimeds Pharmaceuticals US, Inc. is a diversified holding company headquartered in Matawan, New Jersey. Originally founded as a pure-play biotechnology firm, the company’s core medical operations focus on the clinical development and regulatory approval of proprietary, non-opioid, biologic-based therapies for chronic pain management, including its lead Phase III candidate for knee osteoarthritis.

Advanced metrics

Log in or create an account to see advanced metrics history

Holdings comparison

View all public companies →

Bitcoin Treasury Intelligence

Stay ahead of institutional Bitcoin accumulation.

Every week: new treasury entrants, mNAV movements, Digital Credit updates, and the data that matters to serious Bitcoin investors.

No spam. Unsubscribe anytime. Read by institutional analysts worldwide.